Stephen Quake

Stephen Ronald Quake (born 1969) is an American physicist, inventor, and entrepreneur.

Stephen Quake
Quake in 2024
Born	1969 (age 54–55)
Nationality	American
Alma mater	Stanford University (BS, MS) Oxford University (DPhil)
Known for	Microfluidics, genomics
Awards	Lemelson–MIT Prize (2012) Gabbay Award (2015)
Scientific career
Fields	Biophysics, genomics
Institutions	Stanford University, Cornell University
Thesis	Theory and experiments in polymer physics with single molecules of DNA  (1994)
Academic advisors	Robin Stinchcombe, Steven Chu

Education and career

Quake earned his B.S. in physics and M.S. in mathematics from Stanford in 1991 and his D.Phil. in theoretical physics from Oxford University in 1994 as a Marshall Scholar. His thesis research was in statistical mechanics and the effects of knots on polymers. He did his postdoctoral work at Stanford in single-molecule biophysics with Steven Chu. Quake joined the faculty of the California Institute of Technology at the age of 26, where he rose through the ranks and was ultimately appointed the Thomas and Doris Everhart Professor of Applied Physics and Physics. He moved back to Stanford University in 2005 to help launch a new department in Bioengineering, where he is now the Lee Otterson Professor of Bioengineering and Applied Physics. From 2006 to 2016 he was an Investigator of the Howard Hughes Medical Institute. He is an Andrew D. White Professor-at-Large at Cornell University.

Quake was elected a member of the National Academy of Engineering in 2013 for achievements in single-cell analysis and large-scale integration of microfluidic devices. He has also been elected to the National Academy of Sciences, the Institute of Medicine, the American Physical Society, the American Institute for Medical and Biological Engineering and the American Academy of Arts and Sciences.

He is the recipient of numerous international awards, including the Human Frontiers of Science Nakasone Prize, the Jacob Heskel Gabbay Award (2015), the Lemelson–MIT Prize for Innovation, the Raymond and Beverly Sackler International Prize in Biophysics, the NIH Director’s Pioneer Award, the American Society of Microbiology’s Promega Biotechnology Award, and the Royal Society of Chemistry Publishing’s Pioneer of Miniaturization Award. He has founded or co-founded several companies, including Fluidigm, Helicos Biosciences, Verinata Health, Quanticel Pharmaceuticals, Moleculo, Cellular Research and Immumetrix.

Quake is known for his new approaches to biological measurement. He has made contributions to the field of microfluidics, including the invention of microfluidic large scale integration, and developed applications of microfluidics to structural biology, drug discovery, and molecular affinity measurements. He has also made contributions to the field of genomics, including single molecule DNA sequencing, techniques to perform single cell gene expression and genome sequencing, the development of non-invasive prenatal diagnostics to replace amniocentesis, prenatal genome sequencing, non-invasive tests for heart transplant rejection, and the development of approaches to sequence and analyze an individual's immune system. His genome was the subject of clinical annotation by a large team in the Stanford Hospital.

Since 2022, Quake has been the head of the Chan Zuckerberg Institute Science division.

Relationship with He Jiankui

Quake is also known as a former postdoctoral adviser to He Jiankui, the controversial scientist who purportedly created the world's first gene-edited babies. Quake claimed he had told him not to proceed with the experiment.

External links

• Stephen Quake's group at Stanford University
• Lederman, Lynne (July 2007). "Stephen Quake, D. Phil.—At the Interface of Physics and Biology". BioTechniques. 43 (1): 19. doi:10.2144/000112501.